Background

Post-hepatectomy complications have decreased due to technological advances and improved perioperative management. However, post-hepatectomy liver failure, a serious complication, still occurs in 1.2% to 32% of patients after hepatectomy [1, 2]. The occurrence of post-hepatectomy complications is partially related to intraoperative bleeding and perioperative blood transfusion. During hepatectomy, blood loss can be minimized using the Pringle maneuver and low central venous pressure (CVP) management. Maintaining the CVP < 5 cmH2O during hepatectomy reportedly reduces intraoperative bleeding and postoperative complications [3, 4].

CVP measurement involves a static fluid monitoring system; thus, the CVP may not adequately reflect intraoperative fluid volume and tissue oxygen demand. Recently, the Flo Trac system (FTS) has attracted attention as a dynamic fluid monitoring system. The FTS can measure multiple fluid indicators every 20 s, allowing for rapid fluid volume adjustments during surgery [5,6,7]. Among the FTS parameters, intraoperative central venous oxygen saturation (ScvO2) fluctuation (ΔScvO2) is an indicator of increased total bilirubin level after hepatectomy [5].

Although the FTS is reported useful for appropriate intraoperative anesthetic management [5, 7, 8], no study has reported an association between ScvO2 and postoperative complications. The hypothesis of this study is that intraoperative dynamic monitoring will reveal predictors of postoperative complications in hepatectomy. Finally, we propose a novel anesthetic management strategy to reduce the occurrence of postoperative complications.

Methods

In this retrospective cohort study, we enrolled patients who underwent hepatectomy with FTS-monitored anesthetic management in our institution from August 2018 to December 2021. Informed consent for data collection was obtained in the form of an opt-out on the institution website. This study was approved by the ethics review board of our institution (approval number 17–124) in accordance with the ethical guidelines of the Japanese Ministry of Health, Labour, and Welfare regarding clinical studies.

Surgical indication and intraoperative procedures

The extent of hepatectomy was determined based on the primary disease as well as the number and localization of tumors. A major hepatectomy was defined as the removal of one or more segments of the liver. A minor hepatectomy was defined as the removal of less than one segment of the liver. Preoperatively, the indocyanine green test was performed to evaluate the liver function. In patients who underwent major hepatectomy, the remnant K value (remnant liver volume multiplied by indocyanine green disappearance rate) was confirmed to be at least 0.05. Hepatic transection was mainly performed using the Cavitron ultrasonic surgical aspirator (Valleylab, Boulder, CO, USA) and ultrasonic scalpels, with an intermittent application of the Pringle maneuver, which involves clamping the portal triad for 15 and 10 min in patients with normal liver and liver dysfunction, respectively, and releasing the clamp at 5-min intervals. A hemostatic device on the cutting liver surface used saline-coupled soft coagulation of an IO advanced monopolar electrode with a VIO 300 D system (Erbe Elektromedizin GmbH, Tübingen, Germany).

Intraoperative anesthetic management

Each anesthesiologist determined the infusion fluid volume and ventilator settings. During anesthesia, data were collected using a dedicated transducer (FloTrac, Edwards Lifesciences) connected to the radial arterial line and a Vigileo™ monitor (Edwards Lifesciences) or EV1000 Critical Care monitor (Edwards Lifesciences) for continuous monitoring. This monitoring strategy analyzes the pressure waveform 20 times per second for 100 s, captures 2,000 data points for analysis, and performs calculations on the data acquired during the last 20 s. A PreSep central venous oximetry catheter (Edwards Lifesciences) was used to facilitate continuous ScvO2 monitoring [9]. The catheter tip was inserted into the superior vena cava and emitted near-infrared rays, which allowed for continuous blood oxygen saturation measurement. The radial arterial line was connected to the Vigileo™ monitor or EV1000 Critical Care monitor to allow for stroke volume variation (SVV) measurement. The SVV represents the respiratory variability in stroke volume and is affected by the vascular compliance and peripheral resistance. The vascular compliance is estimated from nomograms based on age, sex, height, and weight, whereas the peripheral resistance is determined using radial artery waveforms [10, 11]. In this study, the baseline ScvO2 and ΔScvO2 were defined with a simple modification of previously reported method [5]. The baseline ScvO2 was defined as the average ScvO2 value for 30 min after anesthesia induction. The minimum ScvO2 was defined as the lowest intraoperative ScvO2 value. ΔScvO2 was defined as the difference between the baseline and minimum ScvO2 values (Fig. 1). Moreover, the baseline SVV was defined as the average SVV value for 30 min after anesthesia induction. The maximum SVV was defined as the highest intraoperative SVV value. SVV fluctuation (ΔSVV) was defined as the difference between the baseline and maximum SVV values.

Fig. 1
figure 1

Definitions of baseline and minimum central venous oxygen saturation (ScvO2). The baseline and minimum ScvO2 values are defined as the average ScvO2 value for 30 min after anesthesia induction and the lowest intraoperative ScvO2 value, respectively. ΔScvO2 is defined as the difference between the baseline and minimum ScvO2 values

Classification of postoperative complications

Postoperative complications were classified according to the Clavien-Dindo grading system [12] and evaluated using the comprehensive complication index (CCI), which is a score obtained by weighing all postoperative complications based on their severity [13].

Statistical analysis

Continuous variables were expressed as median (interquartile range) and compared using the Mann–Whitney U-test or Student's t-test. Pearson's chi-square test or Fisher's exact test was used to compare categorical variables. A multivariate logistic regression analysis was performed to identify predictors of postoperative complications. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Statistical analysis was performed using SPSS version 26 (IBM Corp., Armonk, NY, USA), and p-values < 0.05 were considered statistically significant.

Results

Of 93 patients who underwent hepatectomy during the study period at our institute, 58 patients were received anesthetic management with FTS monitoring. We excluded four patients with biliary reconstruction and one patient with aspiration pneumonia-induced in-hospital death. Therefore, 53 patients were enrolled in this study (Fig. 2).

Fig. 2
figure 2

Study flow chart. From August 2018 to December 2021, 58 patients underwent hepatectomy using Flo Trac system (FTS)-monitored anesthetic management. Four and one patients with biliary reconstruction and postoperative death were excluded, respectively. Hence, the 53 included patients were divided into two groups: low (central venous oxygen saturation fluctuation [ΔScvO2] < 10%, n = 36) and high (ΔScvO2 ≥ 10%, n = 17) ScvO2 groups. ΔScvO2 is defined as the difference between the baseline and minimum ScvO2 values

Basic patient characteristics

Forty patients were men. All patients had liver diseases with Child–Pugh and liver damage classifications of A or B. One patient had a history of atrial fibrillation (Table 1).

Table 1 Baseline patient characteristics

Patient characteristics stratified by ΔScvO2 and average SVV

A previous study reported that ΔScvO2 ≥ 10.2% was a significant predictor of postoperative liver dysfunction. Therefore, the 53 patients were divided into two groups: low (ΔScvO2 < 10%, n = 36) and high (ΔScvO2 ≥ 10%, n = 17) ΔScvO2 groups (Fig. 2). There was no significant difference in patient background and preoperative clinicopathological factors between the two groups (Table 2). A previous study reported that intraoperative average SVV ≥ 13.6 was a significant predictor of postoperative liver dysfunction [5]. Hence, the 53 patients were divided into two groups: low (SVV < 13.6, n = 45) and high (SVV ≥ 13.6, n = 8) SVV groups. Additional file 1 compares the patient background, preoperative treatment, and preoperative blood test findings between the two groups. There were significant between-group differences in the levels of total bilirubin (0.7 [0.6–1.0] vs. 1.2 [0.9–1.5] mg/dL; p = 0.019), alkaline phosphatase (239 [199–310] vs. 202 [159–205] IU/l; p = 0.021), γ-glutamyltranspeptidase (55 [27–92] vs. 27 [14–27] IU/l; p = 0.026), and C-reactive protein (0.13 [0.05–0.37] vs. 0.05 [0.03–0.09] mg/dL; p = 0.028) as well as C-reactive protein-to-lymphocyte ratio (CLR) (9.87 [4.88–32.42] vs. 4.49 [2.68–8.36]; p = 0.034) and C-reactive protein-to-albumin ratio (0.030 [0.011–0.097] vs. 0.010 [0.007–0.021]; p = 0.028).

Table 2 Patient data stratified by ΔScvO2

Intraoperative factors stratified by ΔScvO2 and average SVV

Table 2 also shows the intraoperative factors stratified by ΔScvO2. There was a significant between-group difference in the number of patients who underwent major (2/36 vs. 5/17; p = 0.017) and laparotomy (15/36 vs. 13/17; p = 0.018) hepatectomy. Operation time, intraoperative bleeding, intraoperative fluid volume, and hepatectomy time were not significantly different between the two groups. Additional file 1 also presents intraoperative factors stratified by average SVV. Intraoperative bleeding (275 [85–542] vs. 33 [13–86] ml; p = 0.005) was significantly different between the two groups.

Postoperative course stratified by ΔScvO2 and average SVV

Table 2 also shows postoperative course and details of postoperative complications stratified by ΔScvO2. The minimum cholinesterase level (179 [160–216] vs. 160 [124–172] IU/l; p = 0.036) and CCI score (0 [0–14.4] vs. 20.9 [0–24.2]; p = 0.043) were significantly different between the two groups. There was no significant between-group difference in the incidence of complications with Clavien-Dindo grade III or more. High ΔScvO2 tended to associate with more frequent pleural effusion and delayed gastric emptying. There was no patient of post hepatectomy liver failure. Additional file 1 also shows postoperative blood test findings and postoperative course stratified by average SVV. There was no significant between-group difference in the incidence of complications with Clavien-Dindo grade III or more and CCI score.

Patient characteristics stratified by CCI score

The abovementioned results suggested that the intraoperative ΔScvO2 was related to postoperative complication occurrence. Although the cut off value of the CCI is considered to be different depending on each surgical procedures, the median CCI score for the study participants was 20.9; hence, the participants were divided into two groups: low (CCI < 21, n = 45) and high (CCI ≥ 21, n = 8) groups.

Table 3 presents patient characteristics stratified by CCI score. We found no significant between-group difference in patient background and preoperative clinicopathological factors except for CLR (7.51 [4.02–16.39] vs. 24.49 [9.83–101.19]; p = 0.039) in univariate analysis.

Table 3 Patient characteristics stratified by CCI

Intraoperative factors stratified by CCI score

There were significant differences in the number of patients who underwent major hepatectomy (4/45 vs. 3/8; p = 0.028) and in intraoperative bleeding (105 [35–382] vs. 581 [465–694] ml; p = 0.008) (Table 4) in univariate analysis.

Table 4 Intraoperative factors stratified by CCI

FTS measurements stratified by CCI score

We observed a significant between-group difference in the number of patients with ΔScvO2 ≥ 10% (11/45 vs. 6/8; p = 0.010) (Table 5) in univariate analysis. However, the average SVV, maximum SVV, and ΔSVV were not significantly different between the two groups. Furthermore, the pre- and postoperative CVP as well as the maximum intraoperative CVP were not significantly different between the two groups. Lactate levels measured immediately after surgery were not significantly different between the two groups.

Table 5 FTS measurements

ΔScvO2 was an independent predictor of higher CCI scores

Multivariate logistic regression analysis revealed the discriminative capacity of high CCI scores (Table 6). The CLR (median, 9.7), intraoperative bleeding (median, 240 mL), the number of cases with major hepatectomy and ΔScvO2 ≥ 10% were included in the multivariate analysis. The result revealed that ΔScvO2 ≥ 10% (p = 0.016, odds ratio: 9.53) was the only independent predictor of higher CCI scores.

Table 6 Multivariate analysis

Discussion

This study evaluated the intraoperative ScvO2 and SVV measured using the FTS in patients undergoing hepatectomy. ΔScvO2 showed a significant positive correlation with CCI score, whereas, average SVV, maximum SVV, and ΔSVV were not significantly correlated with CCI score. Multivariate analysis identified ΔScvO2 as an independent predictor of elevated CCI scores.

Although recent studies have reported that the mortality rate of patients undergoing hepatectomy is less than 5%, post-hepatectomy complication rates range from 20 to 40%, depending on the extent of resection and liver function [14, 15]. Intraoperative bleeding constitutes a major factor affecting post-hepatectomy outcomes [16, 17]. Intermittent blockage of hepatic blood flow using the Pringle maneuver can reduce intraoperative bleeding; nevertheless, it causes hepatocyte ischemia and reperfusion, leading to liver injury and elevated serum lactate levels [18, 19]. Patients with elevated lactate levels immediately after hepatectomy have a higher risk of postoperative morbidity and mortality [20]. In this study, there was no relationship between the CCI score and postoperative lactate levels. Postoperative lactate level may not be a good predictor of complications in patients undergoing minimally invasive surgery and minor hepatectomy.

Generally, lowering the CVP during hepatectomy reduces hepatic venous and sinusoidal pressures, thereby minimizing bleeding from the liver parenchyma [16, 21]. During hepatectomy, it is recommended to maintain the CVP < 5 cmH2O [3, 22, 23]. However, the CVP is affected by the patient's position during surgery, intrathoracic pressure, and operator compression or clamping of the inferior vena cava, hepatic vein, and portal vein [24]. Furthermore, the CVP is a static hemodynamic monitoring indicator, and thus it is inaccurate for diagnosing fluid deficiencies.

Enhanced recovery after surgery guidelines suggest that dynamic monitoring indicators may replace the CVP as an indicator of fluid responsiveness [25, 26]. Real-time monitoring of the oxygen demand–supply imbalance associated with hepatectomy enables an early detection and treatment of abnormalities and prevents perioperative complications. Previous studies have demonstrated that patients who underwent FTS-monitored anesthetic management had a good postoperative course [6, 27, 28]. The SVV, an FTS-measured indicator of fluid responsiveness, is useful for the perioperative management of patients undergoing highly invasive surgery [6, 29]. Moreover, the SVV is better than the CVP as a predictor of fluid responsiveness during hepatectomy [27]. An intraoperative mean SVV ≥ 13.6 has been reported to increase postoperative total bilirubin levels [5]. However, our study showed no relationship between the SVV and CCI score. Although the SVV is an index of fluid responsiveness, it does not assess tissue oxygenation. The oxygen demand–supply balance may be undisturbed even when the SVV is high. In addition, the SVV cannot be accurately assessed in patients with arrhythmias or in those undergoing laparoscopic surgery [11, 30].

The FTS can also measure the ScvO2, which is an indicator of oxygen demand–supply balance. Oxygen deprivation can lead to mitochondrial dysfunction-induced organ damage [31], which reduces resistance to postoperative stress, thereby increasing the occurrence of postoperative complications. Patients with low intraoperative ScvO2 values are more predisposed to complications after high-risk surgical procedures [32]. During hepatectomy, ischemia–reperfusion injury caused by the Pringle maneuver alters the balance of hepatic oxygen supply [1, 5]. The results of FTS, including ScvO2, are influenced by vascular compliance and peripheral vascular resistance. Vascular compliance is estimated from age, sex, height, and weight [11]. Above mentioned factors were not significantly different between two groups in this study. The optimal cutoff ScvO2 value for predicting postoperative complications differs between healthy patients and those with trauma, severe sepsis, and heart failure [33, 34]. It is difficult to determine the standard ScvO2 value for all patients; nevertheless, the postoperative course can be improved via intraoperative ΔScvO2 suppression. More detailed studies are needed on the factors and mechanisms involved in ScvO2 fluctuations.

Furthermore, we found a relationship between the CCI score and CLR in univariate analysis. Preoperative inflammatory biomarkers have been shown to be associated with the incidence of postoperative complications after esophagectomy [35, 36]. The postoperative course is affected by preoperative lymphocyte count and C-reactive protein levels, which are involved in immune and inflammatory reactions, respectively. CLR is thought to predict the postoperative status better than other inflammatory biomarkers. If the number of cases increases, preoperative CLR may become effective predictor of postoperative complications in hepatectomy.

This study has some potential limitations. First, the anesthetic management method was not standardized; it was selected at the discretion of each anesthesiologist. Therefore, the method used by the anesthesiologist may have influenced intraoperative indicators. Second, the study was a retrospective, single-center cohort with a small sample size. This may cause of the lack of significant differences in ΔScvo2 and individual complications, although a trend was observed for pleural effusions and DGE. Therefore, the study findings should be verified via large-scale, multicenter randomized controlled trials.

In conclusion, ScvO2 monitoring using the FTS can be used as an alternative to CVP monitoring and lactate level measurement to predict the risk of postoperative complications. Given the association between change in ScvO2 and postoperative complications, minimizing the change in ScvO2 is a potential strategy for decreasing the risk of postoperative complications after hepatectomy.